Pharmacogenetics of deoxycytidine kinase: Identification and characterization of novel genetic variants

Journal of Pharmacology and Experimental Therapeutics

Volumn 323, Issue 3, 2007, Pages 935-945

  Lamba, Jatinder K ^a   Crews, Kristine ^a   Pounds, Stanley ^a   Schuetz, Erin G ^a   Gresham, Jessica ^a   Gandhi, Varsha ^b   Plunkett, William ^b   Rubnitz, Jeffrey ^a   Ribeiro, Raul ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DEOXYCYTIDINE KINASE;

3' UNTRANSLATED REGION; ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL LINE; CONTINUOUS INFUSION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ETHNIC DIFFERENCE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LYMPHOBLAST; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIMETABOLITES, ANTINEOPLASTIC; ARABINOFURANOSYLCYTOSINE TRIPHOSPHATE; BLOTTING, WESTERN; CELL LINE, TUMOR; CHILD; DEOXYCYTIDINE KINASE; DNA, COMPLEMENTARY; DRUG ADMINISTRATION SCHEDULE; HUMANS; LEUKEMIA, MYELOID, ACUTE; LINKAGE DISEQUILIBRIUM; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 36348945304     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.128595     Document Type: Article

References (25)

1. Arnér ES, Spasokoukotskaja T, and Eriksson S (1992) Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. Biochem Biophys Res Commun 188:712-718.
2. Colly LP, Peters WG, Richel D, rentsen-Honders MW, Starrenburg CW, and Willemze R (1987) Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia. Semin Oncol 14:257-261.
3. Crews KR, Gandhi V, Srivastava DK, Razzouk BI, Tong X, Behm FG, Plunkett W, Raimondi SC, Pui CH, Rubnitz JE, et al. (2002) Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia. J Clin Oncol 20:4217-4224.
4. Cros E, Jordheim L, Dumontet C, and Galmarini CM (2004) Problems related to resistance to cytarabine in acute myeloid leukemia. Leuk Lymphoma 45:1123-1132.
5. Galmarini CM, Thomas X, Calvo F, Rousselot P, Jafaari AE, Cros E, and Dumontet C (2002) Potential mechanisms of resistance to cytarabine in AML patients. Leuk Res 26:621-629.
6. Hubeek I, Peters GJ, Broekhuizen R, Zwaan CM, Kaaijk P, van Wering ES, Gibson BE, Creutzig U, Janka-Schaub GE, den Boer ML, et al. (2006) In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia. Haematologica 91:17-23.
7. Jin P, Fu GK, Wilson AD, Yang J, Chien D, Hawkins PR, Au-Young J, and Stuve LL (2004) PCR isolation and cloning of novel splice variant mRNAs from known drug target genes. Genomics 83:566-571.
8. Joerger M, Bosch TM, Doodeman VD, Beijnen JH, Smits PH, and Schellens JH (2006) Novel deoxycytidine kinase gene polymorphisms: a population screening study in Caucasian healthy volunteers. Eur J Clin Pharmacol 62:681-684.
9. Johnsamuel J, Eriksson S, Oliveira M, and Tjarks W (2005) Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy. Bioorg Med Chem 13:4160-4167.
10. Kakihara T, Fukuda T, Tanaka A, Emura I, Kishi K, Asami K, and Uchiyama M (1998) Expression of deoxycytidine kinase (dCK) gene in leukemic cells in childhood: decreased expression of dCK gene in relapsed leukemia. Leuk Lymphoma 31:405-409.
11. Kobayashi T, Kakihara T, Uchiyama M, Fukuda T, Kishi K, and Shibata A (1994) Low expression of the deoxycytidine kinase (dCK) gene in a 1-beta-Darabinofuranosylcytosine-resistant human leukemic cell line KY-Ra. Leuk Lymphoma 15:503-505.
12. Kroep JR, Loves WJ, van der Wilt CL, Alvarez E, Talianidis I, Boven E, Braakhuis BJ, Van Groeningen CJ, Pinedo HM, and Peters GJ (2002) Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity. Mol Cancer Ther 1:371-376.
13. Kufe DW, Major PP, Egan EM, and Beardsley GP (1980) Correlation of cytotoxicity with incorporation of ara-C into DNA. J Biol Chem 255:8997-9000.
14. Kufe DW, Munroe D, Herrick D, Egan E, and Spriggs D (1984) Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function. Mol Pharmacol 26:128-134.
15. Major PP, Egan EM, Beardsley GP, Minden MD, and Kufe DW (1981) Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA. Proc Natl Acad Sci U S A 78:3235-3239.
16. Nickerson DA, Tobe VO, and Taylor SL (1997) PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 25:2745-2751.
17. Owens JK, Shewach DS, Ullman B, and Mitchell BS (1992) Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene. Cancer Res 52:2389-2393.
18. 3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study. Exp Hematol 20:1194-1200.
19. Sabini E, Ort S, Monnerjahn C, Konrad M, and Lavie A (2003) Structure of human dCK suggests strategies to improve anticancer and antiviral therapy. Nat Struct Biol 10:513-519.
20. Sarkar M, Han T, Damaraju V, Carpenter P, Cass CE, and Agarwal RP (2005) Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells. Biochem Pharmacol 70:426-432.
21. Shi JY, Shi ZZ, Zhang SJ, Zhu YM, Gu BW, Li G, Bai XT, Gao XD, Hu J, Jin W, et al. (2004) Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients. Pharmacogenetics 14:759-768.
22. Smal C, Vertommen D, Bertrand L, Ntamashimikiro S, Rider MH, Van Den NE, and Bontemps F (2006) Identification of in vivo phosphorylation sites on human deoxycytidine kinase. Role of Scr-74 in the control of enzyme activity. J Biol Chem 281:4887-4893.
23. van der Wilt CL, Kroep JR, Loves WJ, Rots MG, Van Groeningen CJ, Kaspers GJ, and Peters GJ (2003) Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver. Eur J Cancer 39:691-697.
24. Wang JJ, Selawry OS, Vietti TJ, and Bodey GP Sr (1970) Prolonged infusion of arabinosyl cytosine in childhood leukemia. Cancer 25:1-6.
25. Wolfinger RD (1996) Heterogeneous variance: covariance structures for repeated measures. J Agric Biol Environ Stat 1:205-230.